19.01.2011
- Amgen, the world's biggest maker of biotechnology drugs, plans to sell its Fremont, Calif., development and manufacturing plant to Germany's Boehringer Ingelheim, the companies...
13.01.2011
- Merck & Co struck an alliance with contract researcher Parexel International to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called...
22.11.2010
- European regulators adopted a new guideline on so-called biosimilar antibody drugs on Friday, paving the way for cheaper copies of multi-billion-dollar medicines for cancer and...
17.11.2010
- European regulators are expected to adopt a conservative stance this week when they set rules for allowing copies of antibody drugs, used to fight cancer, rheumatoid arthritis and...
14.09.2010
- Amgen on Monday launched $1.5 billion of debt in a two-part sale. The offering includes $900 million of 10-year notes expected to yield 77 basis points over comparable U.S...
04.08.2010
- Sanofi-Aventis has grabbed the headlines with its $18.4 billion bid for Genzyme, but the French drugmaker may be wiser to stick with smaller, bolt-on acquisitions. Sanofi is trying...
18.06.2010
- Amgen is "aggressively" looking at acquisitions, particularly opportunities for international expansion, Chief Executive Kevin Sharer said in a webcast presentation on Thursday....
27.04.2010
- Amgen, the world's largest biotechnology company, said on Monday its chief financial officer, Robert Bradway, has been named president and chief operating officer of the company...
